Clinical Trial

Effect of Ultra-Low Tidal Volume on Mechanical Power During Heart Bypass Surgery

Completed
View on ClinicalTrials.gov →
Summary
The goal of this clinical trial is to evaluate whether ultra-low tidal volume (ULTV) ventilation during cardiopulmonary bypass (CPB) can reduce mechanical power (MP) and improve postoperative respiratory outcomes in adult patients undergoing elective coronary artery bypass graft (CABG) surgery. The main questions it aims to answer are: Does ULTV ventilation during CPB result in lower intraoperative mechanical power compared to apnea? Can ULTV ventilation reduce extubation time and ICU (Intensive Care Unit) stay and improve the PaO₂/FiO₂ ratio (Partial Pressure of Arterial Oxygen / Fraction of Inspired Oxygen Ratio)? Researchers will compare patients receiving ULTV ventilation to those undergoing apnea after aortic cross-clamping to assess the effects on mechanical power and postoperative outcomes. Participants will: Be randomized to either ULTV ventilation or apnea group Undergo standard general anesthesia and CABG surgery Have mechanical power measured at three time points (pre-CPB, post-CPB, and ICU pre-extubation) Have arterial blood gases evaluated for PaO₂/FiO₂ ratios Be monitored for extubation time and ICU length of stay This study aims to generate evidence that could inform safer and more protective intraoperative ventilation strategies during cardiac surgery.
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2025-07-16; most recent amendment 2026-02-26.
Status change: Recruiting → Completed 2026-02-26
Status change: Not Yet Recruiting → Recruiting 2025-11-14
Trial Details
NCT Number NCT07073885
Lead Sponsor Konya City Hospital
Conditions Coronary Artery Disease
Enrollment 60 participants
Start Date 2025-10-10
Primary Completion 2026-02-15 (estimated)
Study Completion 2026-02-20 (estimated)
Updated on ClinicalTrials.gov 2026-03-02